✦ LIBER ✦

78 Controlling survival comparisons to reflect subgroup analyses in phase III clinical trials

✍ Scribed by John Bryant; Birol Emir; H.Samuel Wieand

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ustekinumab safety experience in pat

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

CLinical Experience Acquired with Raptiv

✍ Wolfram Sterry; Georg Stingl; Richard G.B. Langley; Hugh Zacharie; Morad Lahfa; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 German ⚖ 316 KB

CLinical experience acquired with the ef

✍ L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

115 - Immediate hormonotherapy with an L

✍ M. Bolla; D. Gonzalez; P. Warde; J.B. Dubois; R. Mirimanoff; G. Storme; J. Berni 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Long-term safety experience of ustekinum

✍ Kenneth B. Gordon; Kim A. Papp; Richard G. Langley; Vincent Ho; Alexa B. Kimball 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 422 KB

A phase III randomized double-blind plac

✍ Mark M. Schubert; Fernanda P. Eduardo; Katherine A. Guthrie; Jean-Claude Franqui 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 304 KB